RIPK1 and cancer: Thus, consistent with previous reports, these results suggest that the role of RIP1 in cancer cells' response to therapy is complex, and may depend on cell context or cytotoxicity inducers, and the cytoprotective function of RIP1 can be either due to survival promotion or suppression of apoptosis signaling.